Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Mar;58(3):198–203. doi: 10.1136/thorax.58.3.198

Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors

Z Liu 1, J Klominek 1
PMCID: PMC1746590  PMID: 12612292

Abstract

Background: The extracellular matrix metalloproteases (MMPs) produced by tumour and stromal cells are believed to play a key role in tumour cell invasion and metastasis. Malignant mesothelioma is a highly aggressive tumour. Previous studies have shown that malignant mesothelioma cells express MMP-1, -2, -3, -7 and -9. However, the regulation of MMP expression in malignant mesothelioma cells has not been thoroughly investigated.

Methods: The effects of a number of growth factors on the secretion of MMP-2, -3 and -9 in malignant mesothelioma cells were studied by substrate zymography. The expression of relevant growth factor receptors in malignant mesothelioma cells was also examined using RT-PCR.

Results: The exposure of malignant mesothelioma cells to different growth factors including epidermal growth factor (EGF), transforming growth factor-α, amphiregulin, heparin binding EGF, ß-cellulin (BTC), stem cell factor, insulin-like growth factors I and II, acidic and basic fibroblast growth factors, and hepatocyte growth factor increased secretion of MMP-9 and/or MMP-3. EGF receptor ligands BTC and EGF had the most potent effect on MMP-9 and MMP-3 production, respectively. Production of MMP-2 was not affected by any growth factors used in this study. We have also demonstrated mRNA expression of different growth factor receptors in malignant mesothelioma cells, and found that the tyrosine kinase inhibitor genistein inhibited the increased production of MMPs resulting from stimulation with different growth factors.

Conclusion: This study shows, for the first time, the broad extent of regulation of MMPs by various growth factors in malignant mesothelioma cells.

Full Text

The Full Text of this article is available as a PDF (187.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman K. H. Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol. 1981 Sep;8(3):313–320. [PubMed] [Google Scholar]
  2. Benbow U., Brinckerhoff C. E. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 1997 Mar;15(8-9):519–526. doi: 10.1016/s0945-053x(97)90026-3. [DOI] [PubMed] [Google Scholar]
  3. Bielefeldt-Ohmann H., Jarnicki A. G., Fitzpatrick D. R. Molecular pathobiology and immunology of malignant mesothelioma. J Pathol. 1996 Apr;178(4):369–378. doi: 10.1002/(SICI)1096-9896(199604)178:4<369::AID-PATH460>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  4. Bredin C. G., Liu Z., Hauzenberger D., Klominek J. Growth-factor-dependent migration of human lung-cancer cells. Int J Cancer. 1999 Jul 30;82(3):338–345. doi: 10.1002/(sici)1097-0215(19990730)82:3<338::aid-ijc6>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  5. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  6. Harvey P., Clark I. M., Jaurand M. C., Warn R. M., Edwards D. R. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer. 2000 Nov;83(9):1147–1153. doi: 10.1054/bjoc.2000.1445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson L. L., Dyer R., Hupe D. J. Matrix metalloproteinases. Curr Opin Chem Biol. 1998 Aug;2(4):466–471. doi: 10.1016/s1367-5931(98)80122-1. [DOI] [PubMed] [Google Scholar]
  8. Klominek J., Baskin B., Hauzenberger D. Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction. Clin Exp Metastasis. 1998 Aug;16(6):529–539. doi: 10.1023/a:1006542301794. [DOI] [PubMed] [Google Scholar]
  9. Klominek J., Baskin B., Liu Z., Hauzenberger D. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer. 1998 Apr 13;76(2):240–249. doi: 10.1002/(sici)1097-0215(19980413)76:2<240::aid-ijc12>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  10. Klominek J., Robért K. H., Hjerpe A., Wickström B., Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 1989 Nov 1;49(21):6118–6122. [PubMed] [Google Scholar]
  11. Kondapaka S. B., Fridman R., Reddy K. B. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer. 1997 Mar 17;70(6):722–726. doi: 10.1002/(sici)1097-0215(19970317)70:6<722::aid-ijc15>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  12. Kurebayashi J., Otsuki T., Tang C. K., Kurosumi M., Yamamoto S., Tanaka K., Mochizuki M., Nakamura H., Sonoo H. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. Br J Cancer. 1999 Feb;79(5-6):707–717. doi: 10.1038/sj.bjc.6690114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu Z., Ivanoff A., Klominek J. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines. Int J Cancer. 2001 Mar 1;91(5):638–643. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1102>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  14. Myoken Y., Myoken Y., Okamoto T., Kan M., McKeehan W. L., Sato J. D., Takada K. Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth. Int J Cancer. 1996 Mar 1;65(5):650–657. doi: 10.1002/(SICI)1097-0215(19960301)65:5<650::AID-IJC15>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  15. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6133–6137. doi: 10.1073/pnas.82.18.6133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O-charoenrat P., Modjtahedi H., Rhys-Evans P., Court W. J., Box G. M., Eccles S. A. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res. 2000 Feb 15;60(4):1121–1128. [PubMed] [Google Scholar]
  17. Peto J., Decarli A., La Vecchia C., Levi F., Negri E. The European mesothelioma epidemic. Br J Cancer. 1999 Feb;79(3-4):666–672. doi: 10.1038/sj.bjc.6690105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Polosa R., Prosperini G., Leir S. H., Holgate S. T., Lackie P. M., Davies D. E. Expression of c-erbB receptors and ligands in human bronchial mucosa. Am J Respir Cell Mol Biol. 1999 May;20(5):914–923. doi: 10.1165/ajrcmb.20.5.3308. [DOI] [PubMed] [Google Scholar]
  19. Riese D. J., 2nd, Bermingham Y., van Raaij T. M., Buckley S., Plowman G. D., Stern D. F. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene. 1996 Jan 18;12(2):345–353. [PubMed] [Google Scholar]
  20. Riese D. J., 2nd, Stern D. F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 1998 Jan;20(1):41–48. doi: 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  21. Shibata K., Kikkawa F., Nawa A., Suganuma N., Hamaguchi M. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines. Cancer Res. 1997 Dec 1;57(23):5416–5420. [PubMed] [Google Scholar]
  22. Sokolova Irina A., Bubendorf Lukas, O'Hare Anna, Legator Mona S., Jacobson Kris K. B., Grilli B S Bruno, Dalquen Peter, Halling Kevin C., Tamm Michael, Seelig Steven A. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer. 2002 Oct 25;96(5):306–315. doi: 10.1002/cncr.10720. [DOI] [PubMed] [Google Scholar]
  23. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E., Jr Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993 Dec;7(15):1434–1441. doi: 10.1096/fasebj.7.15.8262328. [DOI] [PubMed] [Google Scholar]
  24. Sundareshan P., Nagle R. B., Bowden G. T. EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP. Prostate. 1999 Aug 1;40(3):159–166. doi: 10.1002/(sici)1097-0045(19990801)40:3<159::aid-pros3>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  25. Tzanakakis G. N., Karamanos N. K., Klominek J., Hjerpe A. Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. Biochem Cell Biol. 1995 Jan-Feb;73(1-2):59–66. doi: 10.1139/o95-007. [DOI] [PubMed] [Google Scholar]
  26. Vincenti M. P., White L. A., Schroen D. J., Benbow U., Brinckerhoff C. E. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr. 1996;6(4):391–411. doi: 10.1615/critreveukargeneexpr.v6.i4.40. [DOI] [PubMed] [Google Scholar]
  27. Yokoo T., Kitamura M. Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway. Am J Physiol. 1996 May;270(5 Pt 2):F806–F811. doi: 10.1152/ajprenal.1996.270.5.F806. [DOI] [PubMed] [Google Scholar]
  28. Zhang L., Underhill C. B., Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995 Jan 15;55(2):428–433. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES